Dong-Yeop Shin, M.D., Ph.D.^1*, Sung-Soo Yoon, M.D., Ph.D.¹, Junshik Hong, M.D., Ph.D.¹, Je-Hwan Lee, MD, PhD², Jun-Ho Jang, MD., PhD.³, June-won Cheong, MD, PhD⁴, Ho-Jin Shin, MD^5*, Jeong-Ok Lee, MD⁶, Yoo Jin Lee, MD., PhD.⁷, Jae-Sook Ahn, MD, PhD⁸, Byoung-Sik Cho, MD, PhD^9*, Hee-Je Kim¹⁰, Joseph Clarey, MBBS FRACP FRCPA^11*, Gi-Jun Sung, PhD^12*, Jeejin Im, MS^12*, Ky-Youb Nam, PhD¹³, June Han, PhD^12*, Kyu-Tae Kim, PhD^12*, JeongHyeok Yoon, PhD^12*, Bao Nguyen^14*, Li Li, MD^14* and Donald Small, MD, PhD¹⁴

¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
⁵Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
⁶Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
⁷Division of Hemato-oncology, Department of Internal Medicine, Ulsan University Hospital, Uisan, Korea, Republic of (South)
⁸Chonnam National University Hwasun Hospital, Jeollanam-Do, Korea, Republic of (South)
⁹Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁰Department of Hematology, Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)
¹¹ICON cancer centre, North Mackay, Australia
¹²Pharos iBio Co., Ltd., Anyang, Korea, Republic of (South)
¹³Pharos iBio Co., Ltd., Anyang, South Korea
¹⁴Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

Sylvain Garciaz, MD^1*, Pierre Bories, MD, PhD^2*, Jean-Marie Boher^3*, Marie Anne Hospital, MD, PhD^4*, Christian Récher, MD, PhD⁵, Colombe Saillard, MD^4*, Yosr Hicheri, MD^4*, Renato Monteiro^6*, Olivier Hermine, MD, PhD⁷, Pierre Launay, PhD^6* and Norbert Vey, MD⁸

¹Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France; Centre National de la Recherche Scientifique, UMR7258, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France, Marseille, France
²hematologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
³Institut Paoli Calmettes, Biostatistics Unit, Marseille, France
⁴Department of Hematology, Institut Paoli-Calmettes, Marseille, France
⁵Hematology Department, CHU deToulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁶Inatherys, Evry, France
⁷Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁸Department of Hematology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille, France

Betul Oran, MD, MS¹, David Marin, MD¹, Qaiser Bashir, MD¹, Sairah Ahmed, MD², Amanda L. Olson, MD³, Uday Popat, MD¹, Partow Kebriaei, MD⁴, Elizabeth J. Shpall, MD¹, Vinay Jain, MD, MBBS⁵ and Richard E. Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴M.D. Anderson Cancer Center, Houston, TX
⁵Arog Pharmaceuticals, Inc., Dallas, TX

Cristina Tognon, PhD^1*, Shikha Mishra, MS^1*, Andy Kaempf, MS^2*, Byung Park, PhD^2*, Sunil K Joshi, MD PhD^1,3, Ariane Huang, BS^1*, Stephen E. Kurtz, PhD^1*, Luca Sax, BSc^1*, Christopher A. Eide^1*, Kara Johnson, BSc^1*, Rachel Mahoney, BSc^1*, Michael James Lue, MS^1*, Nicole Tong, BSc^1*, Lisa Guiducci^1*, Tara Lundberg Willians, BSc, MBA^1*, Emma Indira Solanki, MSc^1*, Rachel J. Cook, MD, MS⁴, Jessica T. Leonard, MD⁵, Curtis A Lachowiez, MD¹, Gabrielle Meyers, MD^1*, Jennifer N. Saultz, DO¹, Elie Traer, MD, PhD¹, Jeffrey W. Tyner, PhD¹, Uma Borate, MD⁶ and Ronan T. Swords, MD, PhD, FRCP, FRCPath¹

¹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
²Knight Cancer Institute, Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR
³Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁴Oregon Health & Science University, Portland, OR
⁵Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁶The Ohio State University, Columbus, OH

Amir T. Fathi^1*, Aleksandra Filipovic, MD^2*, Keri Maher, DO³, Dale G Schaar, MD, PhD⁴, Rabin Niroula, MBBS⁵, Joseph J. Maly^6*, Deepa Jaykumar^7*, Noah Merin, MD, PhD⁸, Jay Yang, MD⁹, Jorge R. Galvez Silva, M.D.¹⁰, Varun Gang^11*, Taylor Meeks, BSc^11*, Christopher Korth^2* and Guenther Koehne, MD, PhD¹²

¹Massachusetts General Hospital, Boston
²PureTech Health, Boston, MA
³Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ
⁴Robert Wood Johnson Med. School The Cancer Inst. of NJ (CINJ), New Brunswick, NJ
⁵Legorreta Cancer Center, Lifespan Cancer Institute Providence, Providence, RI
⁶Norton Cancer Institute, Louisville, KY
⁷University of California Irvine Medical Center, Orange, CA, Orange
⁸Hematology and Cellular Therapy, Cedars-Sinai Medical Center, Los Angeles, CA
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Nicklaus Children's Hospital, Miami, FL
¹¹PureTech health, Boston
¹²Baptist Health South Florida, Miami Cancer Institute, Miami, FL

David Taussig, PhD, MRCP, FRCPath¹, David C. de Leeuw, MD, PhD^2*, Mojca Jongen-Lavrencic, MD, PhD³, Jenny O'Nions^4*, Thinzar Koko, MRCP, FRCPath⁵, Emma Searle^6*, Geoff Fisher, PhD^7*, Sue Brook, PhD, MRCP, FFPM^7*, Hendrik-Tobias Arkenau, MD, PhD, FRCP^7*, Ayan Aden Yusuf^7* and Peter T. Tan, MBBS⁸

¹The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
²Amsterdam University Medical Center, Amsterdam, Netherlands
³Erasmus University Medical Center, Rotterdam, Netherlands
⁴University College London Hospital NHS Foundation Trust, London, United Kingdom
⁵Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
⁶The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
⁷Ellipses Pharma, London, United Kingdom
⁸Royal Perth Hospital, Perth, Australia

Ming Hong, MD, PhD^1*, Wenjie Liu, M.D.;Ph.D.^1*, Qian Sun, M.D.;Ph.D.^1*, Jianyong Li, MD² and Sixuan Qian^3*

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Jiangsu Province Hospital, Nanjing, China

Sandra Cohen, MD¹, Nadia M. Bambace, MD², Lea Bernard, MD¹, Imran Ahmad, MD¹, Jean Roy, MD¹, Sylvie Lachance, MD¹, Jean-Sebastien Delisle, MD, PhD³, Thomas L. Kiss, MD¹, Denis-Claude Roy, MD³, Olivier Veilleux, MD¹ and Guy Sauvageau, MD/PhD⁴

¹Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
²Baptist Health South Florida, Miami Cancer Institute, Miami, FL
³Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada
⁴Institut de recherche en Immunologie et Cancer, Université de Montréal, Montreal, QC, Canada

Brian A. Jonas, MD, PhD¹, Zarir E. Karanjawala, MD, PhD,^2*, Laura Molnar, CCRP^3*, Ashley Linh Dang-Chu, CCRP^3*, Mehrdad Abedi, MD^1*, Naseem S. Esteghamat, MD¹, Aaron S. Rosenberg, MD¹, Francisco Andres Socola, MD¹, Lihong Qi, PhD^4* and Joseph M. Tuscano, MD¹

¹Department of Internal Medicine, Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
²Department of Pathology, University of California Davis School of Medicine, Sacramento, CA
³Office of Clinical Research, UC Davis Comprehensive Cancer Center, Sacramento, CA
⁴Division of Biostatistics, University of California Davis, Davis, CA

Wenbing Duan^1*, Chunkang Chang, MD^2*, Zhiguo Wang^3*, Hongbing Ma^4*, Min Ouyang^5*, Xingli Zhao^6*, Lifan Tu^7*, Guodong Wu^8*, Xunqiang Wang^8*, Xiao Jun Huang⁹ and Hao Jiang^10*

¹Department of Hematology, Peking University People's Hospital, Beijing, China
²Hematology department, Shanghai Sixth People's Hospital, Shanghai Jiaotong University school of Medicine, Shanghai, China
³Harbin The First Hospital, Harbin, CHN
⁴West China Hospital, Sichuan University, Chengdu, China
⁵Peking University international Hospital, Beijing, China
⁶Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District,, Tianjin, China
⁷Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, AL, China
⁸Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China
⁹Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
¹⁰Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Susanne Jung^1,2,3*, Annika Nelde^2,3*, Yacine Maringer^2,3*, Monika Denk^2,3,4*, Lisa Zieschang^2,3,4*, Christine Kammer^2,3*, Melek Özbek^2,3,4*, Christopher Hackenbruch^1,3*, Jonas S. Heitmann, MD^5,6*, Helmut R. Salih, MD^5,6* and Juliane S. Walz, MD^2,3,4,5*

¹Clinical Cooperation Unit Translational Immunology, University Hospital Tübingen, Tübingen, Germany
²Institute of Immunology, Peptide-based Immunotherapy, Tübingen University, Tübingen, Germany
³Cluster of Excellence iFIT, Tübingen University, Tübingen, Germany
⁴Partner Site Tübingen, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Tübingen, Germany
⁵Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
⁶DFG Cluster of Excellence 2180 ‘Image-guided and Functional Instructed Tumor Therapy’ (IFIT), University of Tübingen, Tübingen, Germany

Gail J. Roboz, MD¹, Ahmed Aribi, MD^2*, Adrian Ochsenbein, MD³, Carsten Riether, PhD⁴, Monic J. Stuart, MD, MPH⁵, Emily Mitchell^6*, Komal Changela^7*, Adam George^6*, Michael Boyiadzis, MD⁸, Clayton Smith, MD⁹ and Thomas Pabst¹⁰

¹Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
²Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³University Hospital of Bern, Bern, Switzerland
⁴University and University Hospital of Bern, Bern, Switzerland
⁵Clinical Drug Development Consultants, LLC, Hillsborough, CA
⁶Oncoverity, Aurora, CO
⁷oncoverity, Aurora, CO
⁸Genentech, South San Francisco, CA
⁹CU Innovations, University of Colorado, Aurora, CO
¹⁰Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland

Pau Montesinos, PhD, MD^1*, June-Won Cheong, MD, PhD², Naval Daver, MD³, Amir T. Fathi, MD⁴, Mark J. Levis⁵, Selina Luger, MD, FRCPC⁶, Toshihiro Miyamoto, MD, PhD^7*, Esther Natalie Oliva, MD⁸, Alexander E. Perl, MD⁶, Christian Récher, MD^9*, Richard F. Schlenk, MD^10*, Jianxiang Wang, MD¹¹, Amer M. Zeidan, MBBS, MHS¹², Li Liu, PhD^13*, Yvonne Duong, PharmD^13*, Karima Imadalou, MD^13*, Karenza Alexis, MD^13*, Akash Nahar, MD^13*, Kristy Burns, PhD^13* and Harry P. Erba, MD, PhD¹⁴

¹Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
²Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea, Republic of (South)
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Massachusetts General Hospital Cancer Center, Boston, MA
⁵Johns Hopkins University, Baltimore, MD
⁶University of Pennsylvania, Philadelphia, PA
⁷Department of Hematology, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan
⁸U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio di Calabria, Italy
⁹Service d'hématologie, Centre Hospitalo-universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, Service d'hématologie, Toulouse, France
¹⁰NCT-Trial Center, National Center of Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany
¹¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Disease, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
¹²Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
¹³Daiichi Sankyo, Inc., Basking Ridge, NJ
¹⁴Duke University Cancer Institute, Durham, NC

David McCall, MD¹, Branko Cuglievan, MD², Amber Gibson, DO^2*, Miriam B. Garcia, DO^2*, Michael E. Roth, MD² and Cesar Nunez, MD^2*

¹Division of Pediatrics, MD Anderson, Bellaire, TX
²Division of Pediatrics, MD Anderson Cancer Center, Houston, TX